Responding to a recent request for input from the field, the AHA yesterday urged the Center for Medicare and Medicaid Innovation to balance the risk and reward in its alternative payment models “in a way that reflects the significant investments required to launch and maintain APM participation.” It also urged CMMI to “factor implementation periods into any future APMs and reduce mid-model changes to the greatest degree possible,” noting that many AHA members “have indicated they need one to two years to make all the necessary operational, administrative and clinical adjustments to succeed in models.” In addition, AHA urged CMMI to ensure participants “have timely, usable data about their attributed populations,” and “support providers’ ability to deliver accessible, equitable care to patients.” 

Related News Articles

Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation…
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from…
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements. The…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
In this recent episode of AHA’s Advancing Health podcast, Sara Robinson, senior associate healthcare architect at McMillan Pazdan Smith Architecture, and Jamie…
Headline
The AHA March 27 made a series of recommendations to the Physician‐Focused Payment Model Technical Advisory Committee to address barriers to participating in…